Login / Signup
Fahri Akbas
(Fahri Akbaş)
ORCID
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 5
Top Topics
Molecular Docking
Case Control
Gene Expression
Highly Efficient
Top Venues
Clinical and experimental pharmacology & physiology
Journal of neurological surgery. Part A, Central European neurosurgery
Chemical biology & drug design
Molecular neurobiology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Feyzi Sinan Tokalı
,
Halil Şenol
,
Şeyma Ateşoğlu
,
Fahri Akbas
A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies.
Chemical biology & drug design
104 (1) (2024)
Erdem Deveci
,
Fahri Akbas
,
Arif Sanli Ergun
,
Ayse Kurtulmuş
,
Ali Barlas Koçak
,
Rabia Kevser Boyraz
,
Olgu Enis Tok
,
Mehmet Şerif Aydin
,
Özge Kılıç
,
Ayhan Bozkurt
,
Omer Uysal
,
Mukaddes Eşrefoğlu
,
Abdurrahim Koçyiğit
,
Ahmet Ozturk
,
Andrew J Lawrence
,
Ismet Kırpınar
The Effects of Transcranial Focused Ultrasound Stimulation of Nucleus Accumbens on Neuronal Gene Expression and Brain Tissue in High Alcohol-Preferring Rats.
Molecular neurobiology
(2022)
Anas Abdallah
,
Abdurrahim Tekin
,
Mustafa Namik Oztanir
,
Seda Süsgün
,
Ayşegül Yabacı Tak
,
İrfan Çınar
,
Engin Can
,
Sadık Tokar
,
Fahri Akbas
,
Mehmet Hakan Seyithanoglu
Effects of Methylprednisolone in the Treatment of Spinal Cord Injuries by Evaluation of microRNA-21: An Experimental Study.
Journal of neurological surgery. Part A, Central European neurosurgery
(2022)
Leman Yalcintepe
,
Demet Erdag
,
Fahri Akbas
,
Bahire Kucukkaya
Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells.
Clinical and experimental pharmacology & physiology
47 (7) (2020)
Seyma Ceylan
,
Fatemeh Bahadori
,
Fahri Akbas
Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic cancer treatment.
Pharmaceutical development and technology
25 (7) (2020)